8 April 2014 - PHARMAC is seeking feedback on its Named Patient Pharmaceutical Assessment (NPPA) Policy as part of the rolling review of its Operating Policies and Procedures. The NPPA policy has been in place for two years, and in that time it’s also been updated to manage hospital medicines.

PHARMAC is seeking views on the NPPA Policy, and any other issues the public may have with PHARMAC’s provision of subsidies for exceptional circumstances.

For more details, go to: http://www.pharmac.health.nz/news/consultation-2014-04-08-nppa/